Ecto-5′-nucleotidase (CD73)-mediated adenosine production is tissue protective in a model of bleomycin-induced lung injury

被引:103
作者
Volmer, Jonathan B.
Thompson, Linda F.
Blackburn, Michael R.
机构
[1] Univ Texas, Hlth Sci Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA
[2] Grad Sch Biomed Sci, Houston, TX 77030 USA
[3] Oklahoma Med Res Fdn, Immunobiol & Canc Program, Oklahoma City, OK 73104 USA
关键词
D O I
10.4049/jimmunol.176.7.4449
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Adenosine signaling has diverse actions on inflammation and tissue injury. Levels of adenosine are rapidly elevated in response to tissue injury; however, the mechanisms responsible for adenosine production in response to injury are not well understood. In this study, we found that adenosine levels are elevated in the lungs of mice injured by the drug bleomycin. In addition, increased activity of ecto-5'-nucleotidase (CD73) was found in the lungs in conjunction with adenosine elevations. To determine the contribution of CD73 to the generation of adenosine in the lung, CD73(-/-) mice were subjected to bleomycin challenges. Results demonstrated that CD73(-/-) mice challenged with bleomycin no longer accumulated adenosine in their lungs, suggesting that the primary means of adenosine production following bleomycin injury resulted from the release and subsequent dephosphorylation of adenine nucleotides. CD73(-/-) mice challenged with bleomycin exhibited enhanced pulmonary inflammation and fibrosis as well as exaggerated expression of proinflammatory and profibrotic mediators in the lung. Intranasal instillations of exogenous nucleotidase restored the ability of lungs of CD73(-/-) mice to accumulate adenosine following bleomycin challenge. Furthermore, these treatments were associated with a decrease in pulmonary inflammation and fibrosis. CD73(+/+) animals challenged with bleomycin and supplemented with exogenous nucleotidase also exhibited reduced inflammation. Together, these findings suggest that CD73-dependent adenosine production contributes to anti-inflammatory pathways in bleomycin-induced lung injury.
引用
收藏
页码:4449 / 4458
页数:10
相关论文
共 58 条
[1]  
ALI S, 1994, J PHARMACOL EXP THER, V268, P1328
[2]   SIMPLE METHOD OF ESTIMATING SEVERITY OF PULMONARY FIBROSIS ON A NUMERICAL SCALE [J].
ASHCROFT, T ;
SIMPSON, JM ;
TIMBRELL, V .
JOURNAL OF CLINICAL PATHOLOGY, 1988, 41 (04) :467-470
[3]   The equilibrative nucleoside transporter family, SLC29 [J].
Baldwin, SA ;
Beal, PR ;
Yao, SYM ;
King, AE ;
Cass, CE ;
Young, JD .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2004, 447 (05) :735-743
[4]   Why are A2B receptors low-affinity adenosine receptors?: Mutation of Asn273 to Tyr increases affinity of human A2B receptor for 2-(1-hexynyl) adenosine [J].
Beukers, MW ;
Den Dulk, H ;
Van Tilburg, EW ;
Brouwer, J ;
Ijzerman, AP .
MOLECULAR PHARMACOLOGY, 2000, 58 (06) :1349-1356
[5]   Metabolic consequences of adenosine deaminase deficiency in mice are associated with defects in alveogenesis, pulmonary inflammation, and airway obstruction [J].
Blackburn, MR ;
Volmer, JB ;
Thrasher, JL ;
Zhong, HY ;
Crosby, JR ;
Lee, JJ ;
Kellems, RE .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (02) :159-170
[6]   Adenosine deaminase deficiency: Metabolic basis of immune deficiency and pulmonary inflammation [J].
Blackburn, MR ;
Kellems, RE .
ADVANCES IN IMMUNOLOGY, VOL 86, 2005, 86 :1-41
[7]   Adenosine mediates IL-13-induced inflammation and remodeling in the lung and interacts in an IL-13-adenosine amplification pathway [J].
Blackburn, MR ;
Lee, CG ;
Young, HWJ ;
Zhu, Z ;
Chunn, JL ;
Kang, MJ ;
Banerjee, SK ;
Elias, JA .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (03) :332-344
[8]   Too much of a good thing: adenosine overload in adenosine-deaminase-deficient mice [J].
Blackburn, MR .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2003, 24 (02) :66-70
[9]   Impairment of tubuloglomerular feedback regulation of GFR in ecto-5′-nucleotidase/CD73-deficient mice [J].
Castrop, H ;
Huang, YN ;
Hashimoto, S ;
Mizel, D ;
Hansen, P ;
Theilig, F ;
Bachmann, S ;
Deng, CX ;
Briggs, J ;
Schnermann, J .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (05) :634-642
[10]  
CATTANEO M, 1990, BLOOD, V75, P1081